December 2022

Recently, Huaying Capital and Mingzhi Technology jointly invested in the establishment of Suzhou Zhizhi Lightweight Materials Industry Investment Fund Partnership (Limited Partnership). The fund’s total fundraising scale is 300 million yuan, and the first phase of the fundraising amount is 152 million yuan. Among them, Mingzhi Technology intends to subscribe for a capital contribution of […]

Pickme is a logistics service provider that provides a new way of parcel collection. Users can choose to pay (less than 1 euro per package) to ask neighbors to collect and store it on their behalf, and pick up the goods at their convenience. In this way, consumers do not need to wait for the

Pixyle AI is an image recognition solution provider for fashion retailers that trains neural networks utilizing artificial intelligence algorithms to accurately view and interpret images. Pixyle AI recently announced that it has received 1 million euros (about 1.05 million US dollars) in seed round financing, and the investor is South Central Ventures. This article is

Onomotion is a manufacturer of electric tricycles. It mainly combines the flexibility of bicycles with the capacity and durability of trucks to launch ONO, an electric express vehicle, which can provide urban logistics solutions for industry users. Onomotion recently announced a €21 million Series A funding round consisting of €6 million ($6.3 million) in equity

Enwo New Energy is a photovoltaic micro-inverter solution provider, focusing on the research and development and production of photovoltaic micro-inverters, and is committed to becoming a professional provider and manufacturer of distributed photovoltaic power generation solutions. Longci Technology recently announced that the company intends to transfer 41.3792% equity of Enwo New Energy Technology held by

Hero Heart is a shoe manufacturer, which owns the shoe production business in Yongchuan, Vietnam. Huali Group (300979) announced on the evening of December 9 that Hong Kong Hongtai, a wholly-owned subsidiary, plans to acquire 100% equity of Hero Heart International Co., Ltd. for US$63 million (equivalent to approximately RMB 439 million). This article is

Horizon Therapeutics is a drug developer for rare diseases, specializing in the development and production of biosimilar drugs, and is committed to helping patients solve rare diseases and rheumatic diseases. Amgen is closing in on its acquisition of star biotech company Horizon Therapeutics in a deal valued at up to $20 billion, which would be